Literature DB >> 8615643

MAPK activity is down-regulated in human colon adenocarcinoma: correlation with PKC activity.

B M Attar1, M J Atten, O Holian.   

Abstract

Cellular growth is regulated by a cascade of kinases, among which mitogen activated protein kinase (MAPK) is an integral member of the Ras-mediated pathway, while protein kinase C (PKC) is recognized as the intracellular receptor of tumor promoters. To assess the role of these two signal transduction enzymes in colonic carcinogenesis, we measured MAPK and PKC activities in cytosol and membrane compartments of: 1) normal colon, 2) colon adenocarcinoma, and 3) histologically normal colonic tissue taken from the margin of resection of neoplastic colon. Both MAPK and PKC activities were down-regulated in solubilized membranes from the cancers. MAPK activity was also down-regulated in the tissue adjacent to the cancer and designated as histologically normal (by routine histopathology). Therefore, MAPK activity appears to be more suitable than PKC as a marker for early detection of colonic transformation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8615643

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

2.  Expression of EGFR, HER2, phosphorylated ERK and phosphorylated MEK in colonic neoplasms of familial adenomatous polyposis patients.

Authors:  Jayson Wang; James Hollingshead; Nabil El-Masry; Donna Horncastle; Ian Talbot; Ian Tomlinson; Malcolm R Alison; Mona El-Bahrawy
Journal:  J Gastrointest Cancer       Date:  2012-09

3.  c-Jun activation-dependent tumorigenic transformation induced paradoxically by overexpression or block of S-adenosylmethionine decarboxylase.

Authors:  A Paasinen-Sohns; M Kielosto; E Kääriäinen; T Eloranta; A Laine; O A Jänne; M J Birrer; E Hölttä
Journal:  J Cell Biol       Date:  2000-11-13       Impact factor: 10.539

4.  Differential regulation of MAP kinase cascade in human colorectal tumorigenesis.

Authors:  K S Park; N G Kim; J J Kim; H Kim; Y H Ahn; K Y Choi
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

5.  Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer.

Authors:  A Borrero-Palacios; A Cebrián; M T Gómez Del Pulgar; R García-Carbonero; P Garcia-Alfonso; E Aranda; E Elez; R López-López; A Cervantes; M Valladares; C Nadal; J M Viéitez; C Guillén-Ponce; J Rodríguez; I Hernández; J L García; R Vega-Bravo; A Puime-Otin; J Martínez-Useros; L Del Puerto-Nevado; R Rincón; M Rodríguez-Remírez; F Rojo; J García-Foncillas
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

6.  KRAS mutation-independent downregulation of MAPK/PI3K signaling in colorectal cancer.

Authors:  Kuen Kuen Lam; Choong Leong Tang; Emile Tan; Siew Heng Wong; Peh Yean Cheah
Journal:  Mol Oncol       Date:  2022-01-01       Impact factor: 6.603

7.  Characterisation of integrin-linked kinase signalling in sporadic human colon cancer.

Authors:  A Marotta; K Parhar; D Owen; S Dedhar; B Salh
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.